id ndltd-OhioLink-oai-etd.ohiolink.edu-osu1459588788
record_format oai_dc
spelling ndltd-OhioLink-oai-etd.ohiolink.edu-osu14595887882021-08-03T06:35:19Z The Surgical and Management Decision-Making Process of <i>BRCA1</i> and <i>BRCA2</i> Mutation Carriers Puski, Athena Joy Bowen Genetics Health Care Health Care Management BRCA1 BRCA2 HBOC management decision-making risk-reduction risk-reducing surgery surgical decision screening decision surveillance decision ease of decision-making physician doctor genetic counselor decision-making factors Women with a <i>BRCA1</i> or <i>BRCA2</i> mutation have a 40-74% breast cancer risk and 11-46% ovarian cancer risk by age 70. Due to this elevated risk, it is recommended that mutation carriers have increased breast screening and a risk-reducing salpingo-oophorectomy. They are also given the option to have a risk-reducing mastectomy. The process of deciding if and when to undergo prophylactic surgery has been found to be a complex and difficult process for many carriers. To evaluate the decision-making process, recorded interviews were conducted with 20 <i>BRCA1</i> and <i>BRCA2</i> mutation carriers. Information about the cancer risk management decision-making process was analyzed using grounded theory. Factors involved in decision-making, ease of decision-making, and individuals involved in the decision-making process emerged as major themes. Mutation carriers who have not had breast cancer (previvors) were found to have a more difficult time coming to a cancer risk management decision than women with a breast cancer history. Physicians were often discussed as being an integral part of the decision-making process by providing support and management recommendations. Family members and other mutation carriers filled a similar role during the decision-making process by providing decisional and emotional support for carriers. Genetic counselors were short-term providers of risk information and management recommendations for this study population. If a carrier was not receiving the information or support she needed from one of these groups, she often turned to another party, most commonly a healthcare provider. Thus, data from this study suggests that previvors or mutation carriers struggling with the risk management decision-making process may need additional support and information to assist them during this process. It is important that healthcare providers are educated about risk-management strategies for HBOC and work together to best help mutation carriers through the decision-making process. In summary, this study revealed that women with <i>BRCA1</i> and <i>BRCA2</i> mutations utilize physicians, genetic counselors, family members, and other mutation carriers in the cancer risk management decision-making process. The support and assistance from these individuals can impact the decision-making process. 2016-09-12 English text The Ohio State University / OhioLINK http://rave.ohiolink.edu/etdc/view?acc_num=osu1459588788 http://rave.ohiolink.edu/etdc/view?acc_num=osu1459588788 unrestricted This thesis or dissertation is protected by copyright: all rights reserved. It may not be copied or redistributed beyond the terms of applicable copyright laws.
collection NDLTD
language English
sources NDLTD
topic Genetics
Health Care
Health Care Management
BRCA1
BRCA2
HBOC
management
decision-making
risk-reduction
risk-reducing surgery
surgical decision
screening decision
surveillance decision
ease of decision-making
physician
doctor
genetic counselor
decision-making factors
spellingShingle Genetics
Health Care
Health Care Management
BRCA1
BRCA2
HBOC
management
decision-making
risk-reduction
risk-reducing surgery
surgical decision
screening decision
surveillance decision
ease of decision-making
physician
doctor
genetic counselor
decision-making factors
Puski, Athena Joy Bowen
The Surgical and Management Decision-Making Process of <i>BRCA1</i> and <i>BRCA2</i> Mutation Carriers
author Puski, Athena Joy Bowen
author_facet Puski, Athena Joy Bowen
author_sort Puski, Athena Joy Bowen
title The Surgical and Management Decision-Making Process of <i>BRCA1</i> and <i>BRCA2</i> Mutation Carriers
title_short The Surgical and Management Decision-Making Process of <i>BRCA1</i> and <i>BRCA2</i> Mutation Carriers
title_full The Surgical and Management Decision-Making Process of <i>BRCA1</i> and <i>BRCA2</i> Mutation Carriers
title_fullStr The Surgical and Management Decision-Making Process of <i>BRCA1</i> and <i>BRCA2</i> Mutation Carriers
title_full_unstemmed The Surgical and Management Decision-Making Process of <i>BRCA1</i> and <i>BRCA2</i> Mutation Carriers
title_sort surgical and management decision-making process of <i>brca1</i> and <i>brca2</i> mutation carriers
publisher The Ohio State University / OhioLINK
publishDate 2016
url http://rave.ohiolink.edu/etdc/view?acc_num=osu1459588788
work_keys_str_mv AT puskiathenajoybowen thesurgicalandmanagementdecisionmakingprocessofibrca1iandibrca2imutationcarriers
AT puskiathenajoybowen surgicalandmanagementdecisionmakingprocessofibrca1iandibrca2imutationcarriers
_version_ 1719439657215721472